NR4A1 and breast carcinoma: This population-based case-control study provided some evidence to support our hypothesis that the COX-2 .8473 variant C allele may be a genetic modifier for ever use of NSAIDs and reduced breast cancer risk among hormone receptor positive cases, but we observed no corresponding interaction with aspirin use alone, which may be due to reduced power in this subgroup.